SCHEMBL7224799

SCHEMBL7224799

Nc1ccc(CN2COCC2=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.36
MMP2 P08253 1/20 0.35
GFER P55789 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
RAB9A P51151 1/20 0.34
PDE4A P27815 2/20 0.33
PDE4B Q07343 2/20 0.33
PDE4C Q08493 2/20 0.33
PDE4D Q08499 2/20 0.33
POLB P06746 1/20 0.33
LOXL2 Q9Y4K0 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL79013 0.83 GRM2 (0.43) ALDH1A1LMNAL3MBTL1CYP11B1CYP11B2
SCHEMBL5963434 0.82 L3MBTL1 (0.49) ALDH1A1L3MBTL1TSHRPOLB
SCHEMBL4234823 0.76 KLKB1 (0.42) ALDH1A1LMNACYP3A4TSHRTDP1
SCHEMBL2130801 0.72 EGLN1 (0.47) ALDH1A1LMNA
SCHEMBL11043677 0.72 ALDH1A1 (0.52) ALDH1A1LMNAL3MBTL1GFERCYP3A4
SCHEMBL31011701 0.72 RAB9A (0.54) ALDH1A1LMNAGFERCYP11B1CYP11B2
SCHEMBL2223756 0.70 L3MBTL1 (0.70) ALDH1A1LMNAL3MBTL1HRH3
SCHEMBL632892 0.70 L3MBTL1 (0.65) ALDH1A1LMNAL3MBTL1TSHRHRH3
SCHEMBL2136163 0.70 CHRM5 (0.44)
SCHEMBL259624 0.69 GRM2 (0.53) ALDH1A1LMNACYP11B2RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6531604-B2 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect. TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-03-11 US disclosed
US-20020128308-A1 Benzothiepine derivatives, their production and use YASUMA TSUNEO (JP) 2002-09-12 US disclosed
US-6355672-B1 BONE DISORDERS; CENTRAL NERVOUS SYSTEM DISORDERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-03-12 US disclosed
EP-1103552-A1 BENZOTHIEPIN DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128308-A1 Benzothiepine derivatives, their production and use APP, BMP1, BACE1 ALDH1A1 3170/4885LMNA 2119/4885L3MBTL1 3778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.